Could less radiation be just as good for bone cancer pain?

NCT ID NCT06884332

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at whether reducing the amount of spine radiated for painful bone metastases can still effectively relieve pain while possibly causing fewer side effects. About 600 people with spinal bone metastases will be randomly assigned to receive either standard radiation (covering the tumor plus one vertebra above and below) or a smaller radiation field (covering only the tumor and the affected vertebra). The main goal is to compare pain relief at 30 days after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
radiation therapy
What this could lead to
If successful, this could show that smaller radiation fields are just as good for pain relief, with fewer side effects, improving quality of life for people with bone metastases.
What could go wrong
This is a mid-sized trial, but results may not apply to all patients. There is a risk that reducing the radiation area might not control pain as well as the standard approach.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE METASTASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Henri Becquerel Rouen

    RECRUITING

    Rouen, Rouen, 76038, France

  • Centre Hospitalier Universitaire de Brest

    RECRUITING

    Brest, Brest, 29609, France

  • Institut de Cancérologie de Lorraine

    RECRUITING

    Vandœuvre-lès-Nancy, 54511, France

  • Institut de cancérologie de l'Ouest (ICO)

    RECRUITING

    Saint-Herblain, Saint-Herblain, 44805, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.